338 related articles for article (PubMed ID: 7243688)
1. Kinetics of Craviten decomposition in aqueous solutions.
Kubiak Z; Kuncewicz B; Zurańska M
Pol J Pharmacol Pharm; 1980; 32(6):917-25. PubMed ID: 7243688
[TBL] [Abstract][Full Text] [Related]
2. [Investigations on the stability of therapeutic drugs derived from imidazole. XII. Qualitative and quantitative stability evaluation of phentolamine hydrochloride solutions].
Grabowska I; Rajzer D; Kraczkowska A; Kremska B
Acta Pol Pharm; 1990; 47(3-4):29-35. PubMed ID: 12959239
[TBL] [Abstract][Full Text] [Related]
3. Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability of a naphthoquinone in aqueous solutions.
Linares MS; Longhi MR
Pharmazie; 2003 Jan; 58(1):32-7. PubMed ID: 12622250
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of drug decomposition. XXIX. Autoxidation and hydrolysis of thioridazine hydrochloride in aqueous solutions.
Pawelczyk E; Marciniec B
Pol J Pharmacol Pharm; 1974; 26(4):465-72. PubMed ID: 4414040
[No Abstract] [Full Text] [Related]
5. Chemical investigation of decomposition processes of pyrazolidine-3,5-dione derivatives. Part 3. Kinetics and mechanism of degradation of ketazone in aqueous solutions and solid phase.
Wachowiak R
Pol J Pharmacol Pharm; 1978; 30(6):833-43. PubMed ID: 39293
[TBL] [Abstract][Full Text] [Related]
6. Degradation kinetics of butylmethoxydibenzoylmethane (avobenzone) in aqueous solution.
Mbah CJ
Pharmazie; 2007 Oct; 62(10):747-9. PubMed ID: 18236778
[TBL] [Abstract][Full Text] [Related]
7. Stability of ricobendazole in aqueous solutions.
Wu Z; Tucker IG; Razzak M; Medlicott NJ
J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
[TBL] [Abstract][Full Text] [Related]
8. The effect of pH on electronic spectra of butobendin (Craviten) and its spectrophotometric and spectrofluorometric assay in tablets.
Zommer-Urbańska S; Urbańska J
Pol J Pharmacol Pharm; 1984; 36(1):13-8. PubMed ID: 6462957
[TBL] [Abstract][Full Text] [Related]
9. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
Roskar R; Simoncic Z; Gartner A; Kmetec V
J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
[TBL] [Abstract][Full Text] [Related]
10. Stability and degradation profiles of Spantide II in aqueous solutions.
Kikwai L; Babu RJ; Kanikkannan N; Singh M
Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
[TBL] [Abstract][Full Text] [Related]
11. Stability studies of hydralazine hydrochloride in aqueous solutions.
Halasi S; Nairn JG
J Parenter Sci Technol; 1990; 44(1):30-4. PubMed ID: 2313490
[TBL] [Abstract][Full Text] [Related]
12. The stability of aqueous solutions of phenylephrine at elevated temperatures: identification of the decomposition products.
Millard BJ; Priaulx DJ; Shotton E
J Pharm Pharmacol; 1973 Dec; 25():Suppl:24P-31P. PubMed ID: 4150588
[No Abstract] [Full Text] [Related]
13. Stability of ertapenem in aqueous solutions.
Zajac M; Cielecka-Piontek J; Jelińska A
J Pharm Biomed Anal; 2007 Jan; 43(2):445-9. PubMed ID: 16914282
[TBL] [Abstract][Full Text] [Related]
14. Study of erythromycin A decomposition products in aqueous solution by solid-phase microextraction/liquid chromatography/tandem mass spectrometry.
Volmer DA; Hui JP
Rapid Commun Mass Spectrom; 1998; 12(3):123-9. PubMed ID: 9474800
[TBL] [Abstract][Full Text] [Related]
15. [The kinetics of neostigmine degradation in aqueous solution].
Porst H; Kny L
Pharmazie; 1985 Oct; 40(10):713-7. PubMed ID: 4080787
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of drug decomposition. Part XXXI. Autoxidation of narcotine in aqueous solutions.
Pawelczyk E; Zajac M; Remisz M
Pol J Pharmacol Pharm; 1974; 26(5):569-74. PubMed ID: 4427819
[No Abstract] [Full Text] [Related]
17. Kinetics of drug decomposition. Part 48. Specific acid-base hydrolysis of rolitetracycline.
Pawelczyk E; Plotkowiak Z
Pol J Pharmacol Pharm; 1977; 29(4):451-9. PubMed ID: 20613
[TBL] [Abstract][Full Text] [Related]
18. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 1: Identification of decomposition products and mechanism of degradation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidine-dione in an aqueous solution.
Wachowiak R
Arzneimittelforschung; 1979; 29(4):599-602. PubMed ID: 582752
[TBL] [Abstract][Full Text] [Related]
19. The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous solutions.
Simoncic Z; Roskar R; Gartner A; Kogej K; Kmetec V
Int J Pharm; 2008 May; 356(1-2):200-5. PubMed ID: 18304767
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and mechanism of degradation of some 5-allylbarbituric acid derivatives. Part 2: Mechanism of 5.5-diallylbarbituric acid degradation as a function of pH.
Hermann T
Pharmazie; 1976 Jun; 31(6):368-72. PubMed ID: 8793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
